IASLC, LCRF Announce First Recipients of Joint Team Science Award Aimed at Finding a Cure for Oncogene-Driven Lung Cancers
Haleigh BehrmanDr. David Barbie and his team will receive a 4-year, $2.5 million grant to support their research on immune-based approaches to target drug-resistant cancer cells. Read more
Prof. Benjamin Besse said the TKI showed encouraging clinical activity in patients who were heavily pre-treated. Read more
Dr. Alexander Drilon said most patients with ALK-positive NSCLC treated with NVL-655 showed disease regression and deep responses. Read more
Older Age Alone Does Not Preclude Benefit From Early Detection
Krithika Subramanian, PhDDr. Matt Warkentin says in those without significant comorbidity and who are fit for surgery, screening may provide survival benefits. Read more
Burden of Lung Cancer Care and Treatment Takes a Toll Beyond Pocketbooks
Krithika Subramanian, PhDDr. Katie Smith says pragmatic clinical trials reveal the impact of symptom burden in young patients. Read more
Positive Impact of Asbestos Bans on Burden of Asbestos-Related Lung Cancer May Take Several Decades
Krithika Subramanian, PhDDr. Li said a considerable global burden of asbestos-related lung cancers and mesothelioma persists, even as beneficial impact of national asbestos bans are awaited. Read more
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
Fred GebhartDuring the session, Dr. Hisao Asamura reviewed the criteria changes in the new 9th edition of the TNM classification recommendations. Read more
IASLC Recognizes Champions of Lung Cancer Advocacy and Research with STARS Scholar Program
Haleigh BehrmanThe IASLC’s Supportive Training for Advocates on Research and Science Program Provides Tools, Resources, and Education to Aspiring Patient Research Advocates. Read more
IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology
Erin JungmeyerTuesday morning, nine expert clinicians and researchers in the field will give award lectures in honor of their contributions to the treatment of lung cancer. Read more
Session to Report Results of IASLC’s First Diversity, Equity, and Inclusion Survey
Fred GebhartDrs. Narjust Florez and Cecilia Pompili will co-chair the session, which will also include tips for improving inclusion in clinical trials, creating a mutually respective work environment, and more. Read more